INTRODUCTION {#SEC1}
============

2-Amino-3-methylimidazo\[4,5-*f*\]quinoline (IQ) is one of the heterocyclic amines (HCAs) found in cooked meat ([@B1]). HCAs in cooked food are formed by the Maillard reaction when reducing sugars and amino acids are heated. Even though typical human exposure to HCAs is modest, one study estimates a level of ∼60 ng/day ([@B2]); such low levels may still contribute to the etiology of human cancer ([@B3]). IQ is produced in cooked meats at ppb levels ([@B4],[@B5]). It is also present in tobacco smoke ([@B6]). IQ is a potent bacterial mutagen and reasonably anticipated to be a human carcinogen by the National Toxicology Program ([@B3],[@B7],[@B8]). In rodents and nonhuman primates its primary target organ is the liver. IQ induces tumors in the liver, zymbal gland, skin, and clitoral glands of rats, in the liver, lung, and forestomach of mice, and in the liver of nonhuman primates ([@B9]--[@B11]).

The carcinogenic effects of IQ stems from its ability to form DNA adducts after bioactivation ([@B12]). Cytochrome P450 1A2 oxidizes IQ to its *N*-hydroxylamine, which is acetylated by *N*-acetyl transferase, particularly NAT2 (Figure [1](#F1){ref-type="fig"}) ([@B13],[@B14]). Either the *N*-acetoxy-IQ or the nitrenium ion formed by its solvolysis acts as the ultimate carcinogen and reacts with DNA (Figure [1](#F1){ref-type="fig"}) ([@B15]). Oxidative DNA damage, which may occur during its metabolic activation, does not appear to be involved in IQ-induced carcinogenesis ([@B16]). IQ forms a major DNA adduct (dG-C8-IQ) at the C8-position of 2′-deoxyguanosine (dG), and a less abundant *N*^2^-dG adduct ([@B17]--[@B19]). The latter was shown to be more persistent in rodents due to slower repair ([@B20]). In Ames' *Salmonella typhimurium* assay, IQ is a potent inducer of two-base deletions in the CpG dinucleotide repeat sequences of the *HisD3052* target sequence (5′-CGCGCGCG-3′), as are many other aromatic amines and nitroaromatic compounds ([@B8],[@B21]). Site-specific studies showed that the C8-dG adducts formed by 1-nitropyrene, and 1,6- and 1,8-dinitropyrenes induce dinucleotide deletions in repetitive CpG sequences in *Escherichia coli*, whereas predominantly base substitutions were detected in simian kidney cells ([@B22]--[@B24]). Similar to the CpG repeat sequence, the *Nar*I restriction sequence 5′-CG~1~G~2~CG~3~CC-3′ is a notable mutational hot spot for frameshift mutations for the C8-dG adduct of *N*-acetyl-2-aminofluorene, particularly when the adduct is located at G~3~, but it induces only base substitutions in simian kidney cells ([@B25]--[@B27]). The discovery of a new family of bypass polymerases (pols) in recent years suggested that the differences in mutational outcome of the DNA lesions in different cells and organisms may stem from the differences in pols that bypass them ([@B28]). Bulky DNA adducts such as the ones formed by IQ block replicative DNA pols, but a group of specialized DNA pols, referred to as the translesion synthesis (TLS) DNA pols, can bypass them ([@B29]--[@B32]). These TLS pols are more error-prone on undamaged templates, even though some of them can bypass specific DNA damages efficiently and with high fidelity ([@B33],[@B34]). In eukaryotic cells, efficient TLS is carried out cooperatively by two sequential steps ([@B35],[@B36]). In the first step, one of the TLS pols replaces the stalled replicative pol and inserts a nucleotide opposite the DNA lesion. In the subsequent step, this TLS pol may be replaced by another TLS pol, which extends the primer a few nucleotides beyond the lesion site before it gets replaced by the replicative pol to continue DNA synthesis. The requirement of accessory proteins for efficient TLS has also been recognized ([@B37],[@B38]). In eukaryotic cells, TLS is carried out by pol η, pol κ, pol ι and Rev1 of the Y-family pols and pol ζ of the B-family enzymes ([@B32],[@B39]).

![Metabolic activation and the major DNA adduct formation by IQ.](gkv750fig1){#F1}

*In vitro* studies with some of these pols established that pol δ, a replicative pol of the B-family, is completely blocked by the IQ adducts ([@B40]). When present in the *Nar*I restriction site, human pol η extended primers beyond dG-C8-IQ better than did pol κ and much better than pol ι and pol δ ([@B40]). TLS by pol η was determined to be largely error-free. In a cell, however, TLS is significantly more complex, and how the polymerase bypassing the DNA lesion is selected and recruited is yet to be determined ([@B41]). In the current study, we investigated in human cells the roles of different TLS pols in bypassing dG-C8-IQ located in the three different guanine sites of the *Nar*I restriction sequence. We report herein that dG-C8-IQ is highly mutagenic in human embryonic kidney (HEK) 293T cells inducing mainly G→T transversions. We also show that pol η is most efficient in its TLS, which occurs primarily in an error-free manner. In contrast, pol κ and pol ζ together are responsible for majority of the mutagenic bypass.

MATERIALS AND METHODS {#SEC2}
=====================

Materials {#SEC2-1}
---------

ypol ζ, hpol κ and Rev1 were purchased from Enzymax (Lexington, KY). The dNTP solutions (100 mM) were purchased from New England Biolabs (Ipswich, MA) or GE Healthcare (formerly Amersham Biosciences, Piscataway, NJ). \[γ -32P\]ATP was purchased from Perkin Elmer (Waltham, MA). dG-C8-IQ modified oligonucleotides were prepared as previously reported ([@B40]). Unmodified oligonucleotides were purchased from Midland Certified Reagents (Midland, TX).

siRNAs {#SEC2-2}
------

Synthetic siRNA duplexes against PolH (SI02663619), PolK (SI04930884), PolI (SI03033310), Rev1 (SI00115311) and negative control siRNA (1027280) were purchased from Qiagen (Valencia, CA), whereas the same for Rev3 was purchased from Integrated DNA Technologies (Coralville, IA). Sequences of all the siRNAs have been reported ([@B42]).

Methods {#SEC2-3}
-------

### Construction and characterization of a pMS2 vector containing a single dG-C8-IQ and its replication in HEK293T cells {#SEC2-3-1}

We have constructed a single adduct-modified single-stranded vector, pMS2, with neomycin and ampicillin resistance genes, similarly as reported elsewhere ([@B24],[@B43]). The HEK293T cells were grown to ∼90% confluency and transfected with 50 ng of construct in 6 μl of Lipofectamine cationic lipid reagent (Invitrogen, Carlsbad, CA). Following transfection with modified or unmodified pMS2, the cells were allowed to grow at 37°C in 5% CO~2~ for 48 h and the plasmid DNA was collected and purified ([@B44]). It was used to transform *E. coli* DH10B, and transformants were analyzed by oligonucleotide hybridization followed by DNA sequence analysis ([@B24],[@B45]).

### TLS assay in human cells {#SEC2-3-2}

The lesion-containing or control pMS2 construct was mixed with equal amount of a single-stranded pMS2 DNA construct containing a different DNA sequence where the 12-mer oligonucleotide was inserted (i.e. 5′-GTGCGTGTTTGT-3′ in place of 5′-CTCG~1~G~2~CG~3~CCATC-3′) into the gapped plasmid in a manner similar to the construction of the dG-C8-IQ (or control) construct. The mixed DNA was used to transfect HEK293T cells and processed as described above. Oligonucleotide probes for the complementary sequences for both the wild type and the mutant plasmid were used to analyze the progeny. The mutant DNA was used as an internal control and it gave equal number of progeny as the control construct.

### Mutational analyses of TLS products from human cells with pol knockdowns {#SEC2-3-3}

Prior to transfection of the control and dG-C8-IQ-containing vectors, synthetic siRNA duplexes were transfected into HEK293T cells using Lipofectamine. HEK293T cells were plated in 6-well plates at 50% confluence. After 24 h incubation, they were transfected with 100 pmoles of siRNA duplex mixed with Lipofectamine, diluted in Opti-MEM (Gibco), per well. One day before transfection of the plasmid, cells were seeded in 24-well plates at 70% confluence. Cells were then co-transfected with another aliquot of siRNA and either control plasmid or lesion-containing plasmid at a ratio of 2:1. After 24 h incubation, progeny plasmids were isolated as described earlier.

### Reverse transcriptase-polymerase chain reaction (RT-PCR) analysis {#SEC2-3-4}

Total RNA was extracted from the cells 72 h after the first transfection of siRNA duplexes and 100 ng of total RNA was used for RT-PCR analysis. Using primers specific to TLS DNA polymerases and GAPDH as the control gene, siRNA knockdown efficiency was determined as previously described ([@B42],[@B46]). Reverse transcription and PCR initial activation step were performed for 30 min at 50°C and 15 min at 95°C, respectively. Details of amplification of PolH, PolK, PolI and Rev1 as well as GAPDH were described in detail in ([@B42]). RT-PCR products were analyzed on 2% agarose gel run at 100V for 3 h in 1 × TBE buffer.

### Western blotting {#SEC2-3-5}

The specifics of the procedure have been reported in ([@B42]). Briefly, cells were washed with cold phosphate buffered saline and lysed in ice-cold RIPA buffer containing protease inhibitor cocktail. After 1 h incubation on ice, the mixture was centrifuged at 10 000 rpm for 15 min at 4°C, and the protein concentration determination and Western blotting were performed on the supernatant. The protein extracts were boiled in loading sample buffer. Proteins were separated on either 5% or 7% SDS-PAGE gels by electrophoresis for 2 h and transferred onto PVDF membranes. The membranes were blocked with 5% milk and incubated with antibodies that specifically recognize human PolH, PolK, PolI, Rev3 or Rev1. Human β-actin antibody was used to confirm equal gel loading. Horseradish peroxidase-conjugated goat anti-rabbit and goat-anti mouse were used at 1:5000 dilutions. The signals were developed using Pierce ECL Western Blotting Substrate and the images were taken using a PhosphorImager.

*In vitro* assay {#SEC2-4}
----------------

### Labeling and annealing of oligonucleotides {#SEC2-4-1}

The primer was 5′ end-labeled using T4 polynucleotide kinase with \[γ-^32^P\]ATP and purified on a Biospin column (BioRad, Hercules, CA). Template and ^32^P-labeled primer (1:1 molar ratio) were annealed in Tris-HCl buffer (50 mM, pH 7.5) by heating at 90°C for 5 min and then slowly cooling to room temperature (r. t.).

### Single-nucleotide incorporation assays {#SEC2-4-2}

^32^P-labeled primers were annealed to either the unmodified or the dG-C8-IQ modified template, and extension reactions were then carried out in the presence of single dNTPs. All reactions were initiated by the addition of the dNTP solution (100 μM) to preincubated enzyme/DNA mixtures giving a final reaction volume of 20 μl. The final concentrations of the components for the incorporation assays were in Tris-HCl (50 mM, pH 7.5), DNA duplex (10 nM), ypol ζ (2.5, 5 or 10 nM) or Rev1 (2.5, 5.0 and 10 nM), dithiothreitol (DTT, 5 mM), bovine serum albumin (BSA, 50 μg/ml^−1^), NaCl (50 mM) and MgCl~2~ (5 mM). The ypol ζ reactions were run at 37°C for 2 h. Reactions were quenched with equal volume of EDTA (20 μl, 20 mM) in 95% formamide (v/v) containing xylene cyanol and bromophenol blue dyes. Aliquots (20 μl) were separated by electrophoresis on a denaturing gel containing urea (8.0 M) and 16% acrylamide (w/v) (from a 19:1 acrylamide/bisacrylamide solution, AccuGel, National Diagnostics, Atlanta, GA) with Tris borate buffer (80 mM, pH 7.8) containing EDTA (1 mM). The gel was exposed to a PhosphorImager screen (Imaging Screen K, Bio-Rad) overnight. The bands were visualized with a PhosphorImaging system (Bio-Rad, Molecular Imager FX) using the manufacturer\'s Quantity One software, version 4.3.0.

### Full-length extension assay with all four dNTPs {#SEC2-4-3}

The unmodified or dG-C8-IQ modified template was annealed to the ^32^P-labeled 0-primers (with a 3′-C, A or T) and extended in the presence of all four dNTPs (100 μM each) at 37°C for ypol ζ for 5 or 24 hr, and hpol κ for 5 h. Each reaction was initiated by adding the mixture of the dNTP solution to a preincubated enzyme/DNA mixtures in Tris-HCl (50 mM, pH 7.5) buffer containing DNA duplex (10 nM), ypol ζ (0.2, 0.4, 1.0, 2 and 3.3 nM) or hpol κ (2.0, 3.3, 5.0, 10, 30 nM), DTT (5 mM), BSA (50 μg/ml^−1^), NaCl (50 mM) and MgCl~2~ (5 mM), giving a final reaction volume of 20 μl. Reactions were quenched by the addition of equal volume of EDTA (20 mM) in 95% formamide (v/v) containing xylene cyanol and bromophenol blue dyes. Aliquots (20 μl) were separated by electrophoresis on a denaturing gel containing urea (8.0 M) and 16% acrylamide (w/v) (from a 19:1 acrylamide/bisacrylamide solution, AccuGel, National Diagnostics, Atlanta, GA) with Tris borate buffer (80 mM, pH 7.8), containing EDTA (1 mM). Gels were exposed to a PhosphorImager screen (Imaging Screen K, Bio-Rad) overnight. The bands were visualized with a PhosphorImaging system (Bio-Rad, Molecular Imager FX) using the manufacturer\'s Quantity One software, version 4.3.0.

RESULTS {#SEC3}
=======

Roles of pol η, κ and ζ in TLS of dG-C8-IQ {#SEC3-1}
------------------------------------------

The strategy for construction of the adduct containing vector, its replication in human cells and analyses of the progeny has been described ([@B24],[@B47]) and is summarized in Scheme [1](#F8){ref-type="fig"}. In order to define the replication blocking characteristics of dG-C8-IQ in human cells and to identify the pols involved in its TLS, we employed the siRNA approach to constrain expression of specific TLS pol(s) in HEK293T cells. The knockdown was determined to be at least 70% efficient in each case ([@B42]). As an internal control, a construct in which a different unmodified 12-mer oligonucleotide has been ligated into the gap was mixed with the lesion containing plasmid prior to transfection. The percentages of the colonies originating from each dG-C8-IQ-containing plasmid relative to that from the unmodified plasmid, indicating the percentage of TLS, were determined by oligonucleotide hybridization. In HEK293T cells, in which the cells were also transfected with negative control (NC) siRNA, the frequency of TLS was 58%, 62% and 81% for the dG-C8-IQ located at G~1~, G~2~ and G~3~, respectively, relative to 100% progeny generated from the undamaged plasmid (Figure [2](#F2){ref-type="fig"}). This suggests that the IQ adduct is bypassed significantly more efficiently by one or more pols at G~3~ than at either G~1~ or G~2~. The largest decrease in TLS efficiency was observed in cells with knockdown of pol η with the adduct located at each of the three sites (∼57%, 47% and 28% reduction for the G~3~, G~2~ and G~1~ constructs, respectively relative to wild type), followed by pol ζ (45% reduction in the G~3~ construct relative to 42% and 25% reduction in the G~2~ and G~1~ constructs, respectively) and pol κ (36%, 37% and 18% reduction for the G~3~, G~2~ and G~1~ constructs, respectively). Next, we evaluated the effect of simultaneous knockdown of pol η/pol ζ and pol κ/pol ζ on TLS (Figure [2](#F2){ref-type="fig"}). Knockdown of pol η/pol ζ showed the most pronounced effect on TLS, resulting in up to 70% reduction in viability of the dG-C8-IQ plasmid at G~3~. Taken together, we conclude that pol η and pol ζ play critical roles in TLS of dG-C8-IQ, although pol κ also is important.

![General protocol for construction of dG-C8-IQ-containing pMS2 plasmid and its replication in HEK293T cells. Mutational analyses of the progeny were carried out by oligonucleotide hybridization. The 15-mer left (LP) and 15-mer right (RP) probes were used to select plasmids containing the correct insert, and transformants that did not hybridize with both the left and right probes were omitted. A probe containing the complementary 14-mer wild type sequence (WTP) was used to analyze the progeny plasmids. An example of a wild type progeny is shown by the green circle. Any transformant that hybridized with the left and right probes but failed to hybridize with the 14-mer wild type probe (as shown by the red circle) was considered a putative mutant and subjected to DNA sequence analysis.](gkv750fig8){#F8}

![Effects of siRNA knockdowns of TLS pols on the extent of replicative bypass of dG-C8-IQ. Percent TLS in various pol knockdowns was measured relative to an internal control in which a different 12-mer oligonucleotide was inserted (i.e. 5′-GTGCGTGTTTGT-3′ in place of 5′-CTCG~1~G~2~CG~3~CCATC-3′) into the gapped plasmid in a manner similar to the construction of the dG-C8-IQ (or control) construct. The data represent the means and standard deviations of results from two independent experiments. HEK293T cells were treated with negative control (NC) siRNA (WT), whereas the other single or double pol(s) knockdowns are indicated above the bar. TLS result from each knockdown experiment was considered statistically significant (*P* \< 0.05) compared to that from HEK 293T cells treated with NC siRNA. The *P*-value of %TLS for each knockdown was calculated by using two-tailed, unpaired Student\'s *t*-test.](gkv750fig2){#F2}

Error-free and error-prone bypass of dG-C8-IQ in HEK 293T cells {#SEC3-2}
---------------------------------------------------------------

DNA sequence analysis showed that dG-C8-IQ is mutagenic in HEK293T cells in all three sites (Figure [3](#F3){ref-type="fig"}). However, mutational frequency (MF) was remarkably high in the progeny derived from the G~3~ construct relative to the other two sites. Fifty percent of the progeny from G~3~ were mutants, compared to 18% from G~1~ and 24% from G~2~. The major types of mutations observed in each case were targeted G→T transversions (Figures [4](#F4){ref-type="fig"} and [5](#F5){ref-type="fig"}). Knockdown of pol η resulted in an increase in MF, which was most pronounced at G~3~ (26% increase in MF in the progeny from G~3~ relative to 14% and 10% increase in the same from G~1~ and G~2~, respectively). In contrast, MF at each site was decreased when pol κ, ι, ζ or Rev1 was knocked down (Figures [3](#F3){ref-type="fig"} and [4](#F4){ref-type="fig"}). The extent of decrease in MF in each site was most evident in pol κ-knockdown cells. MF of the progeny derived from the G~1~, G~2~ and G~3~ constructs, respectively, were reduced by 47%, 67% and 38% upon knockdown of pol κ. We conclude that pol η is involved in a greater fraction of error-free bypass of dG-C8-IQ, whereas pol ι, pol ζ, Rev1 and especially pol κ each participate in the error-prone TLS of this adduct. Simultaneous knockdown of two polymerases showed that the lack of each two-pol combination resulted in further decrease in MF. For example, a decrease in MF was observed when pols η and κ were simultaneously knocked down, which was most pronounced when the adduct was located at G~3~ (Figures [3](#F3){ref-type="fig"} and [5](#F5){ref-type="fig"}); knockdown of pols η and κ individually exhibited opposite effects on the MF (Figures [3](#F3){ref-type="fig"} and [4](#F4){ref-type="fig"}). Simultaneous knockdown of pol ζ and Rev1, likewise, decreased MF at each site much more than either pol individually (Figures [3](#F3){ref-type="fig"} and [5](#F5){ref-type="fig"}). However, a remarkable synergy on the reduction of MF was observed when pols κ and ζ were simultaneously knocked down. MF of the progeny from the G~1~ and G~3~ constructs was reduced from 18% and 50%, respectively, to less than 3%, whereas it was reduced from 24% to less than 1% in the progeny from the G~2~ construct (Figures [3](#F3){ref-type="fig"} and [5](#F5){ref-type="fig"}). Triple-pol knockdown of pol κ, pol ζ and Rev1 further reduced the MF of the progeny from each dG-C8-IQ construct. Based on this result, we conclude that the most critical role in the error-prone TLS of the dG-C8-IQ adduct is played by pols κ and ζ, whereas pol ι likely has a relatively minor role.

![Mutational frequency of dG-C8-IQ in the progeny from the G~1~, G~2~ and G~3~ constructs in HEK293T cells also transfected with NC siRNA (WT) or siRNA for single, double or triple pol(s) knockdowns (as indicated above the bar) is shown. The data represent the average of two independent experiments (presented in Supplementary Table S1 A--J in the SI).](gkv750fig3){#F3}

![The types and frequencies of mutations induced by dG-C8-IQ in the progeny from the G~1~, G~2~ and G~3~ constructs in HEK293T cells also transfected with NC siRNA (293T) or siRNA for single pol knockdowns are shown in a pie chart. O represents other mutations. The data represent the average of two independent experiments (presented in Supplementary Table S1 A--F in the SI).](gkv750fig4){#F4}

![The types and frequencies of mutations induced by dG-C8-IQ in the progeny from the G~1~, G~2~ and G~3~ constructs in HEK293T cells also transfected with NC siRNA (293T) or siRNA for double or triple pol(s) knockdowns are shown in a pie chart. D and O, respectively, represent targeted deletions and other mutations. The data represent the average of two independent experiments (presented in Supplementary Table S1 G--J in the SI).](gkv750fig5){#F5}

*In vitro* TLS of dG-C8-IQ by eukaryotic pols {#SEC3-3}
---------------------------------------------

An earlier *in vitro* study showed that human pol η extended primers beyond dG-C8-IQ adduct at either G~1~ or G~3~ more efficiently than pol ι or pol κ ([@B40]), but no *in vitro* TLS experiment using pol ζ or Rev1 was conducted. Consequently, we evaluated bypass of dG~3~-C8-IQ with these specialized pols. We found that yeast pol ζ (ypol ζ) (Figure [6A](#F6){ref-type="fig"}) and Rev1 (Supplementary Figure S1 in SI) were unable to incorporate a nucleotide opposite dG~3~-C8-IQ. Another possible role for pols ζ and κ is to extend from a dG~3~-C8-IQ:N template-primer junction. Indeed, we observed that ypol ζ was able to extend dG~3~-C8-IQ:N base pairs, where N is C, A or T, by at least one nucleotide (Figure [6B](#F6){ref-type="fig"} and Supplementary Figure S2 in SI). The three primers represent the major replication outcomes observed in the cell mutagenesis studies. Interestingly, further extension of three or more nucleotides past the lesion was ∼4-fold more efficient (22% versus 5%) for the dG~3~-C8-IQ:A pair than dG~3~-C8-IQ:C pair, implying pol ζ\'s critical role in error-prone TLS of dG-C8-IQ (Figure [6B](#F6){ref-type="fig"}). Extension of the dG~3~-C8-IQ:T pair by three or more bases was modest (\<2%) (Supplementary Figure S2 in SI). Extension of the dG~3~-C8-IQ:N pair was observed for pol κ, where N is A or T but not C, but only at a high protein concentration (Figure [7A](#F7){ref-type="fig"}). Extension of three or more nucleotides past the lesion site was ∼8 and 5% for N = A and T, respectively. Interestingly, intermediate extension products for pol κ seemed to be in lower abundance than for the ypol ζ extension, suggesting that insertion of a first nucleotide past the dG~3~-C8-IQ:N pair (+1 position) may be rate limiting for pol κ. We examined pol κ\'s ability to extend a C:G template-primer (+1 primer) terminus containing the dG~3~-C8-IQ:N pair (at the 0-position). Pol κ efficiently extended the primer when N was C and A while extension of the primer containing the dG~3~-C8-IQ:T pair was modest (Figure [7B](#F7){ref-type="fig"}). This suggests that pol κ can extend the primer after another TLS pol inserts nucleotides opposite the lesion and its 5′ base.

![*In vitro* insertion and extension assay of the dG~3~-C8-IQ adduct by ypol ζ. (**A**) Insertion of dCTP opposite a control unmodified dG (left) and reaction of the dG-C8-IQ modified oligonucleotide in the presence of all four dNTPs. (**B**) Extension of the dG~3~-C8-IQ adduct when paired with C or A after 5 (left) and 24 (right) h.](gkv750fig6){#F6}

![(**A**) Extension past a dG~3~-C8-IQ:N pair (N = C, A and T; 10 nM) by hpol κ after 5 h at 37°C in the presence of all four dNTPs (100 μM). (**B**) Primer extension of a G:C primer template terminus (+1 position) and dG~3~-C8-IQ:N pair (N = C, A and T; 0-position) by hpol κ after 5 h at 37°C in the presence of all four dNTPs (100 μM). The DNA concentration was 10 nM.](gkv750fig7){#F7}

DISCUSSION {#SEC4}
==========

TLS polymerases active in bypassing dG-C8-IQ {#SEC4-1}
--------------------------------------------

Bulky DNA adducts such as dG-C8-IQ are known to block DNA replication ([@B40]). *In vitro* studies showed that the carbocyclic analog of dG-C8-IQ is a strong replication block to *E. coli* DNA polymerase I, exo-free Klenow fragment, exo-free DNA polymerase II and Dpo4 ([@B48]). In another study pol δ was completely inhibited by dG-C8-IQ, whereas human pol η extended primers beyond the adduct site more efficiently than pol κ and much better than pol ι for each adducted G in the *Nar*I sequence ([@B40]).

The results of our current study suggest that each TLS polymerase examined in this work, including pol η, pol κ, pol ι and Rev1 of the Y-family and pol ζ of the B-family, plays a role in bypassing dG-C8-IQ, as the number of colony-forming units reduced with knockdown of any of these pols (Figure [2](#F2){ref-type="fig"}). Even so, as determined in the case of the C8-dG adduct of 3-nitrobenzanthrone (dG-C8-ABA) ([@B42]), none of the TLS pols are essential for TLS of dG-C8-IQ. Knockdown of either pol η or pol κ reduced the TLS efficiency 20--40% (Figure [2](#F2){ref-type="fig"}), but in each case the magnitude was higher with pol η knockdown, which is consistent with the *in vitro* result showing a more efficient TLS of this adduct by pol η ([@B40]). It is worth mentioning that based on a crystal structure analysis of a series of C8-dG aromatic amine adducts, it was concluded that destacking of the aromatic moiety of the adduct on top of the primer-template base pair is a key prerequisite for the efficient bypass by pol η ([@B49]). Knockdown of the B-family enzyme, pol ζ, also showed a reduction in TLS, the magnitude of which was intermediate between that of the two Y-family pols (Figure [2](#F2){ref-type="fig"}). This suggests that each of these three pols plays a role in TLS of dG-C8-IQ. Simultaneous knockdown of pol η and pol ζ showed a marked effect on TLS, resulting in up to 70% reduction in viability of the dG-C8-IQ plasmid at G~3~. Therefore, pol η and pol ζ seem to play a key role in TLS of dG-C8-IQ.

These results also show that the magnitudes of the TLS are different at different sequence contexts. The conformation of dG-C8-IQ is expected to be different at each sequence context, although it remains in a *syn* orientation about the glycosyl bond ([@B50]). It is conceivable that TLS pols accommodate various conformation of the DNA adduct in its active site involving both Watson−Crick and non-Watson−Crick hydrogen bonding to bypass bulky lesions in DNA, such as the dG-C8-IQ. Accordingly, the context effect of TLS likely reflects a subtle difference in the conformation of the DNA adduct.

Error-free versus error-prone TLS {#SEC4-2}
---------------------------------

It is interesting to note that dG-C8-IQ is bypassed more efficiently when positioned at G~3~, and it is also the most mutagenic site. A large fraction of TLS at G~3~, therefore, occurs in an error-prone manner. Of the different single pol knockdown experiments, an increase in MF was seen in pol η-knockdown cells, whereas the largest reduction in MF occurred upon knockdown of pol κ (Figures [3](#F3){ref-type="fig"} and [4](#F4){ref-type="fig"}). Error-free TLS, therefore, is largely carried out by pol η, which is consistent with the previous *in vitro* TLS studies ([@B40]). Nevertheless, knockdown of pol η increases MF by only 10--26%, suggesting that other TLS pols can also perform error-free TLS. In contrast, pol κ and pol ζ appear to be the most critical pols involved in erroneous TLS, as evidenced by the greatest synergy in lowering MF upon simultaneous knockdown of these two pols (Figures [3](#F3){ref-type="fig"} and [5](#F5){ref-type="fig"})). Since pol ζ has been shown to be an extender after a nucleotide has been inserted opposite a DNA lesion ([@B51]--[@B53]), we postulate that a TLS pol misincorporates dATP (or less frequently dTTP) opposite dG-C8-IQ and the mispair is extended by pol ζ. As a proof of concept, we have performed *in vitro* TLS using ypol ζ, which showed that it can extend dG-C8-IQ:A pair more efficiently than when the adduct is paired with C, whereas it is inefficient in nucleotide incorporation opposite this DNA adduct (Figure [6B](#F6){ref-type="fig"}). It is likely that the catalytic activity of pol ζ extension of dG-C8-IQ would be improved in the presence of the accessory subunits, as demonstrated recently with cisplatin ([@B54]). The identity of the polymerase that misincorporates dATP and dTTP is not clear. Rev1 and pol κ have roles in mutagenesis as evident from the knockdown experiments (Figures [3](#F3){ref-type="fig"}--[5](#F5){ref-type="fig"}); however, neither could efficiently insert a nucleotide opposite the dG~3~-C8-IQ lesion *in vitro* (Supplementary Figure S1 in SI and ([@B40])). It is possible that they act together and/or are more active in the presence of accessory proteins. Rev1 has already been shown to act as a template for erroneous DNA synthesis by recruiting pol κ ([@B55]). It is also conceivable that pol κ plays a non-catalytic role in dG-C8-IQ bypass.

In a recent study, we appraised the error-free and error-prone TLS of dG-C8-ABA using the approach similar to the one described here ([@B42]). In the dG-C8-ABA study, pol η and pol κ were identified as the major contributors of the mutagenic TLS, while Rev1\'s non-catalytic role by physically interacting with the other two pols was postulated. In contrast, pol ζ was involved in the error-free bypass of dG-C8-ABA. These results are significantly different from the results of the current investigation, suggesting that the structure and conformation of the C8-dG adduct determines how the TLS pols would carry out TLS. It is also interesting to note that, unlike the error-prone TLS of dG-C8-IQ, pol κ and pol ζ together promote error-free replication of *cis*-thymine glycol, a product of oxidative DNA damage ([@B56]).

In conclusion, dG-C8-IQ is mutagenic in HEK293T cells inducing mainly G→T transversions. In the *Nar*I sequence, the lesion is most mutagenic when located at G~3~. Of the bypass pols, pol η is not only the most efficient, but it can perform TLS of dG-C8-IQ alone in an error-free manner. In contrast, pol κ and pol ζ cooperatively carry out the mutagenic TLS.
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